Correction: Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures.

Verroken, Alexia;Defourny, Lydwine;le Polain de Waroux, Olivier;Belkhir, Leïla;Glupczynski, Gerald;et.al.
(2016) PLoS One — Vol. 11, n° 9, p. e0160537 [1-4] (2016)

Files

pone0160537.pdf
  • Open Access
  • Adobe PDF
  • 585.12 KB

Details

Authors
  • Author
  • Defourny, LydwineUCLouvain
    Author
  • le Polain de Waroux, OlivierUCLouvain
    Author
  • Author
  • Laterre, Pierre-FrançoisUCLouvain
    Author
  • Author
  • Glupczynski, GeraldUCLouvain
    Author
Show more
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0156299.].
Affiliations

Citations

Verroken, A., Defourny, L., le Polain de Waroux, O., Belkhir, L., Laterre, P.-F., Delmée, M., & Glupczynski, G. (2016). Correction: Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures. PLoS One, 11(9), e0160537 [1-4]. https://doi.org/10.1371/journal.pone.0160537 (Original work published 2016)